To explore how many signaling transduction pathways might participate in FLJ10540-mediated cell migration and invasion in lung cancer cells, we first investigated three well-defined signaling pathways, namely the PI3K/AKT, p38, and MAPK pathways, using pharmacological inhibitors. This evidence concerns the gene AKT1 and lung cancer.